C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/1986
12/10/1986	EP0204480A2 Synthetic vaccines for foot and mouth disease
12/10/1986	EP0204401A1 Method of improving the yield of polypeptides produced in a host cell by stabilizing mRNA
12/10/1986	EP0204179A1 Method for selectively increasing the ratio of single major components of teicoplanin A2 complex
12/09/1986	US4628032 Monoclonal antibody specific for a mammary tumor cytoplasmic antigen
12/04/1986	WO1986007093A1 Process for preparing heterogenic protein
12/04/1986	WO1986007062A1 Monoclonal antibody to decay accelerating factor (daf), a method for making it, and use
12/04/1986	WO1986007060A1 Cloning and expression of host-protective immunogens of ibdv
12/03/1986	EP0203587A2 Ras oncogene peptides and antibodies
12/03/1986	EP0203552A2 Monoclonal antibodies for human non-small cell lung carcinomas
12/03/1986	EP0203418A1 Oligopeptide derivatives, their preparation and their use as tensides with a good tolerance to the skin
12/03/1986	EP0203382A2 Process for the preparation and purification of alpha-interferon
12/03/1986	EP0203177A1 Polypeptides and antibodies related to deglycosylated viral glycoproteins
12/03/1986	CN85109132A Dna clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity
12/02/1986	US4626525 Antibiotics, preparation and use of and intermediates therefor
12/02/1986	CA1214738A1 Molecular cloning and characterization of the gene sequence coding for porcine relaxin
11/1986
11/26/1986	EP0202975A2 Soluble interleukin-2 receptor as an indicator of malignancy and a method of assaying the same
11/26/1986	EP0202642A2 Process for the in vitro immunization of human splenocytes against tumor associated antigens
11/26/1986	EP0202470A1 Cloning and expression of delta-endotoxin genes of bacillus thuringiensis in bacterial cells and products therefrom
11/26/1986	CN86103528A Method for selectively increasing the ratio of single major components of teicoplanin a2 complex
11/26/1986	CN86103254A Process for the preparation of adducts of dipeptide and amine
11/26/1986	CN86102889A Improved method for man-promoting growth factor c
11/25/1986	US4624925 Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigens, antibody, and methods
11/25/1986	US4624921 Cultures, fusion
11/25/1986	US4624918 Purification process for hepatitis surface antigen and product thereof
11/25/1986	CA1214413A1 Antibiotic a51568 factors a and b
11/25/1986	CA1214411A1 Process for the preparation of immune interferon
11/25/1986	CA1214405A1 Human t cell hybridomas
11/25/1986	CA1214389A1 Encapsulated cells, their method of preparation and use
11/20/1986	WO1986006745A1 MOLECULAR CLONING OF cDNA FOR HUMAN FACTOR VIIIR (VON WILLEBRAND FACTOR)
11/20/1986	WO1986006744A1 A cDNA MOLECULE CODING FOR THE EXPRESSION OF AN INTERFERON alpha TYPE POLYPEPTIDE, A BACTERIAL OR CELLULAR HOST TRANSFORMED WITH SUCH MOLECULE AND A POLYPEPTIDE SHOWING INTERFERON ACTIVITY PREPARED BY SUCH HOST
11/20/1986	WO1986006636A1 Monoclonal antibody
11/20/1986	WO1986006635A1 Oral vaccines
11/20/1986	EP0201855A2 Process for manufacturing addition compounds of dipeptides and amines
11/20/1986	EP0201716A2 Expression of immunologically reactive viral proteins
11/20/1986	EP0201520A1 Monoclonal antibodies and their use
11/20/1986	EP0201519A1 Monoclonal antibodies and their use
11/19/1986	CN85108890A Methods of preparing covalently-modified neutral bacterial poly-saccharides and thereof covalent conjugates of such polysaccharides and immunogenic proteins
11/18/1986	US4623733 Antimicrobial peptide
11/18/1986	US4623714 Antidiabetic
11/18/1986	US4623627 Monoclonal antibody having specificity for the double-stranded conformation of native DNA and diagnostic methods using same
11/18/1986	CA1214129A1 Mammalian cell line producing growth hormones, preferably human and vectors used to obtain same
11/18/1986	CA1214127A1 Method for introducing cloned, amplifiable genes into eucaryotic cells and for producing proteinaceous products
11/18/1986	CA1214126A1 Method for protecting a bacterium from a naturally occurring bacteriophage
11/18/1986	CA1214123A1 Cell lines for use in the preparation of hybridoma cells
11/18/1986	CA1214122A1 Poliovirus-neutralizing-monoclonal antibodies and hybridomas secreting said antibodies
11/12/1986	EP0201416A1 Particles having immunogen HBs antigen properties and bearing an antigenic site, foreign to the epitopes of HBs antigen, vectors and animal cells for the production of those particles of mixed vaccines
11/12/1986	EP0201239A1 Process for the isolation of fermentation products
11/12/1986	EP0201208A1 Supersecreting mutants of saccharomyces cerevisiae
11/12/1986	EP0201187A1 Determination of glycated (glycosylated) hemoglobin in blood
11/12/1986	EP0201086A2 Method of producing useful high-molecular-weight substances by culturing proliferous animal cells and culture system therefor
11/12/1986	EP0201079A2 Delayed solid phase immunologic assay
11/12/1986	EP0200986A1 Recombinant human interleukin-1
11/12/1986	EP0200909A2 Preparation of protein G and/or fragments thereof
11/12/1986	EP0200767A1 Sandwich immunoassay of antigens involved in ophthalmic disorders.
11/12/1986	EP0200757A1 Promotion of wound healing with human epidermal growth factor prepared from recombinant dna.
11/12/1986	CA1213841A Hybrid cell line for producing complement-fixing monoclonal antibody to mouse i-a antigen and to i-a analogous antigens on human and other animal lymphocytes, antibody and methods
11/07/1986	EP0108787A4 The manufacture and expression of structural genes.
11/06/1986	WO1986006494A2 Means for in vitro diagnostic of malignant cells originating from the digestive tube
11/06/1986	WO1986006413A1 Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof
11/06/1986	WO1986006410A1 Process for increasing yield of interleukin-2
11/06/1986	WO1986006409A1 High level amplification and expression of exogenous dna
11/06/1986	WO1986006408A1 HIGH YIElD PRODUCTION OF ACTIVE FACTOR IX
11/06/1986	WO1986006407A1 IDENTIFICATION OF AN IgE-BINDING PROTEIN BY MOLECULAR CLONING
11/06/1986	WO1986006406A1 Vectors for the expression and secretion of hirudin by transformed yeasts
11/06/1986	WO1986006385A1 Method for purifying interferon and composition of matter produced thereby
11/06/1986	WO1986004217A3 Protein hydrolysates, production process and drugs containing th em
11/05/1986	EP0200655A1 Expression and secretion vectors for hirudine by way of transformed yeasts
11/05/1986	EP0200653A1 Hybrid cells producing a hepatitis B virus antigen obtained from hepatocytes and established monkey cells, process for the obtention of these hybrid cells and use thereof in the production of this antigen
11/05/1986	EP0200554A2 Hybridomas producing monoclonal antibodies specific for mouse interleukin-2
11/05/1986	EP0200464A2 A tumor associated antigen
11/05/1986	EP0200421A2 Expression of factor VII activity in mammalian cells
11/05/1986	EP0200417A2 Production of protein
11/05/1986	EP0200280A2 Oxidation resistant IL-2 muteins and their production, formulations containing such muteins, and DNA sequences and expression vectors coding for such muteins and corresponding transformed host cells
11/05/1986	EP0200231A2 Methods for preparing rabbit monoclonal antibodies, the cell lines used therein and the antibodies produced thereby
11/05/1986	EP0199769A1 Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides
11/05/1986	EP0199756A1 Monoclonal antibodies and their use
11/05/1986	EP0199755A1 Monoclonal antibodies and their use
11/05/1986	EP0199754A1 Monoclonal antibodies and their use
11/05/1986	EP0093436B1 Process for preparing permanent animal and human cell lines, and their use
11/05/1986	CN86102090A Procedure for obtaining, dna, rna, peptides, polypeptides, or proteins by recombinant dna techemiques
11/04/1986	US4621054 Biologically active substance, process for preparing the substance and immunoactive composition
11/04/1986	US4621052 Process for the production of human epidermal growth factor
11/04/1986	US4621051 Process for the production of human multiplication-stimulating activity
11/04/1986	CA1213544A1 Process for producing target cell lysis factor and uses therewith
11/04/1986	CA1213540A1 Bacterial production of heterologous polypeptides under the control of a repressible promoter-operator
11/04/1986	CA1213539A2 Bacterial polypeptide expression employing tryptophan promoter-operator
11/04/1986	CA1213538A1 Dna fragments coding for an immunogen peptide liable of inducing in vivo the synthesis of anti-poliovirus antibodies
11/04/1986	CA1213537A1 Polypeptide expression method
11/04/1986	CA1213536A1 Monoclonal antibody, method of producing the same and use thereof
10/1986
10/29/1986	EP0199698A2 Process for the extraction and purification of proteins from culture media producing them
10/29/1986	EP0199586A2 Tumour-associated antigen
10/29/1986	EP0199568A2 Method for purifying interferon and composition of matter produced thereby
10/29/1986	EP0199480A2 Hepatitis A virus vaccines
10/29/1986	EP0199301A1 Recombinant acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS
10/29/1986	EP0199196A2 Monoclonal antibody and method for the production thereof
10/29/1986	EP0199141A2 Monoclonal antibodies to human gastrointestinal cancer
10/29/1986	EP0199091A1 Process for the production of a herpes simplex virus type 2 specific antigen, suitable agents therefor and the use of this antigen
10/29/1986	EP0199018A2 Expression in e.coli of hybrid polypeptides containing the growth hormone releasing factor sequence
10/29/1986	EP0198866A1 Monoclonal antibodies and their use
10/29/1986	CN86102977A Production of protein

1 ... 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 ... 1125